Skip to main content
. 2014 Oct 29;308(3):F179–F197. doi: 10.1152/ajprenal.00455.2014

Fig. 1.

Fig. 1.

Effect of renal medullary interstitial infusion (R.I.) of the SOD inhibitor diethyldithiocarbamic acid (DETC) on mean arterial pressure (MAP) and renal cortical and medullary laser-Doppler flow (LDF; A) and urine flow and sodium and potassium excretion (B). *P < 0.05 compared with control. Reprinted with permission from Zou et al. (206).